While GRPR‐based imaging is particularly beneficial for detecting low‐grade prostate cancer and lesions unaffected by hormonal treatment, PSMA imaging is more effective in high‐grade prostate cancer and post‐hormone therapy cases. This evidence concerns the gene FOLH1 and prostate carcinoma.